about
Emergence of a New Highly Successful Acapsular Group A Streptococcus Clade of Genotype emm89 in the United KingdomEmerging role of the interleukin-8 cleaving enzyme SpyCEP in clinical Streptococcus pyogenes infectionChemokine-cleaving Streptococcus pyogenes protease SpyCEP is necessary and sufficient for bacterial dissemination within soft tissues and the respiratory tract.Superantigenic activity of emm3 Streptococcus pyogenes is abrogated by a conserved, naturally occurring smeZ mutationInactivation of the CovR/S virulence regulator impairs infection in an improved murine model of Streptococcus pyogenes naso-pharyngeal infectionNon-invasive monitoring of Streptococcus pyogenes vaccine efficacy using biophotonic imagingRocA truncation underpins hyper-encapsulation, carriage longevity and transmissibility of serotype M18 group A streptococci.Panton-Valentine leucocidin expression by Staphylococcus aureus exposed to common antibioticsScarlet Fever Upsurge in England and Molecular-Genetic Analysis in North-West London, 2014.Molecular analysis of an outbreak of lethal postpartum sepsis caused by Streptococcus pyogenes.The IL-8 protease SpyCEP/ScpC of group A Streptococcus promotes resistance to neutrophil killing.Impact of immunization against SpyCEP during invasive disease with two streptococcal species: Streptococcus pyogenes and Streptococcus equiIdentification of commonly expressed exoproteins and proteolytic cleavage events by proteomic mining of clinically relevant UK isolates of Staphylococcus aureus.Emergence of a novel lineage containing a prophage in emm/M3 group A Streptococcus associated with upsurge in invasive disease in the UK.Community outbreaks of group A Streptococcus revealed by genome sequencing.Enhanced nasopharyngeal infection and shedding associated with an epidemic lineage of emm3 group A Streptococcus.Turner et al. Reply to "Emergence of the Same Successful Clade among Distinct Populations of emm89 Streptococcus pyogenes in Multiple Geographic Regions".A truncation in the regulator RocA underlies heightened capsule expression in serotype M3 group A streptococci.Streptococcus pyogenes under pressure.Clinical and Molecular Epidemiology of Staphylococcal Toxic Shock Syndrome in the United Kingdom.The DNases of pathogenic Lancefield streptococci.Proteomic analysis at the sites of clinical infection with invasive Streptococcus pyogenes.Specific C-terminal cleavage and inactivation of interleukin-8 by invasive disease isolates of Streptococcus pyogenes.Impact of contusion injury on intramuscular emm1 group a streptococcus infection and lymphatic spreadIdentification of two new core chromosome-encoded superantigens in Streptococcus pyogenes; speQ and speRStreptococcal superantigen-induced expansion of human tonsil T cells leads to altered T follicular helper cell phenotype, B cell death and reduced immunoglobulin releaseEmergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological studyToxic Shock Syndrome Toxin 1 Evaluation and Antibiotic Impact in a Transgenic Model of Staphylococcal Soft Tissue InfectionHigh burden and seasonal variation of paediatric scabies and pyoderma prevalence in The Gambia: A cross-sectional studyThe Emergence of Successful Streptococcus pyogenes Lineages through Convergent Pathways of Capsule Loss and Recombination Directing High Toxin Expression
P50
Q28383363-388108B0-008F-4D0A-8F46-88BC6C341FFFQ33646539-00025BC6-9F5E-4281-929A-43F953A5BE39Q33996850-BA5F5BAC-1C6A-4AD7-834E-22026DBAEC6FQ34437647-659EF010-B839-480D-8827-07FE1D631413Q34700515-F9745A94-8BC3-497A-98CA-4A0631DC84D5Q35054131-BBFE5E0A-A5CC-482A-B445-545855C519A3Q35075140-C63ABE2F-6A81-4FEC-A929-C85239FF0651Q35949711-A2C1DF72-E164-4E95-866E-70D75F309BDDQ36935283-4693564F-10A9-4BC0-A3A2-6E88CCB6DF79Q36971031-A7AFAD17-7F88-4074-8156-8585E9357F8EQ37074095-71BBDB27-1C5B-4428-BD1A-68E5F1EB6F07Q37380367-8E3FE2BF-4808-4F0B-A946-11F6FC4534B9Q37658080-CF0CC658-33F5-47E9-A59C-45C3630E7312Q37658207-B980FF4C-859B-4879-AD18-29F95B5B703BQ38619163-E92B9CCD-2CAB-4EF9-8779-B8D7DC440BD0Q40231465-571BD2E4-CEA6-401A-9575-ADCB6B058F8AQ43143841-08A458E3-7550-44B1-AF95-11284A1DF5BFQ43190765-B4602794-0CAD-4FE9-B8AC-A400EA4E00EDQ44313776-3DEE7B0D-3CB5-4E2F-B48A-547653AA32AAQ47723974-829C92DE-55EB-4874-A67A-05A94F91A000Q49838538-215331E3-9DC5-429B-92BD-3FDD1CC62A39Q52589111-5A1D1D8D-2FA0-4BFC-8A45-9797166D0D69Q53662483-F850E105-277C-4ABD-BAD4-176CCEE1A775Q56967866-00B39583-8DE3-40E9-8E39-D698ED2F8015Q63859430-870FC2D3-2690-420B-9073-0830A4FD3E3AQ63859432-6F7A1E42-8BB3-4B5C-ABC4-7D101C5B14A4Q90099454-C1A90D8F-F315-4312-B0C8-8421249118AEQ90616376-00559C7C-EF07-43B5-90D6-18B9AA9FF7DEQ90694057-F634E1ED-A138-4EC9-A524-AD8579B10396Q91853578-2A7A6986-BD7F-4495-8096-679AC1420563
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Claire E Turner
@ast
Claire E Turner
@en
Claire E Turner
@es
Claire E Turner
@nl
Claire E Turner
@sl
type
label
Claire E Turner
@ast
Claire E Turner
@en
Claire E Turner
@es
Claire E Turner
@nl
Claire E Turner
@sl
prefLabel
Claire E Turner
@ast
Claire E Turner
@en
Claire E Turner
@es
Claire E Turner
@nl
Claire E Turner
@sl
P106
P21
P31
P496
0000-0002-4458-9748